Followers | 277 |
Posts | 56617 |
Boards Moderated | 20 |
Alias Born | 08/29/2007 |
Sunday, August 18, 2024 12:10:02 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent PALI News
- Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 • GlobeNewswire Inc. • 11/12/2024 01:45:00 PM
- Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC) • GlobeNewswire Inc. • 11/07/2024 01:30:00 PM
- Palisade Bio Announces Positive Data from Two Ex Vivo Translational Studies of PALI-2108 for the Treatment of Ulcerative Colitis • GlobeNewswire Inc. • 10/31/2024 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/30/2024 10:05:20 AM
- Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC) • GlobeNewswire Inc. • 10/10/2024 12:30:00 PM
- Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC • GlobeNewswire Inc. • 10/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:31:12 PM
- Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis • GlobeNewswire Inc. • 09/25/2024 12:00:00 PM
- Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
- Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/19/2024 12:00:00 PM
- Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:11:13 PM
- Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Palisade Bio Participates in Virtual Investor “What this Means” Segment • GlobeNewswire Inc. • 07/31/2024 01:15:00 PM
- Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 07/29/2024 12:30:00 PM
- Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 07/19/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:19:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:13:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:10:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 09:15:31 PM
- Palisade Bio to Participate in the Virtual Investor Closing Bell Series • GlobeNewswire Inc. • 06/24/2024 01:00:00 PM
- Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences • GlobeNewswire Inc. • 06/21/2024 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 01:41:55 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM